RecruitingNot ApplicableNCT06073678

Photobiomodulation in Palate Wounds: Somatosensorial Evaluation

Photobiomodulation in Gingival Graft Donor Areas: Clinical, Somatosensory, and Quality of Life Evaluations


Sponsor

University of Sao Paulo

Enrollment

30 participants

Start Date

Oct 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to compare the effects of photobiomodulation with red laser on gingival graft donor areas of the palate in comparison to only protection with wound dressing. The main questions it aims to answer are: Does photobiomodulation on the palate promote faster somatosensory recovery? Does photobiomodulation reduce pain in palate donor sites, improving the quality of life? Participants who need gingival graft surgeries will receive laser irradiation on the palate donor area or just protection with wound dressing. Data will be collected up to 60 days. Researchers will compare protection on the palate and protection plus laser irradiation to see if laser therapy may reduce pain and accelerate somatosensory normalization. Moreover, they will measure changes in the quality of life after treatment.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Inclusion Criteria2

  • Palate with normal and healthy mucosa
  • Patient with indication of gingival graft surgery

Exclusion Criteria5

  • Patients using prosthesis with palate coverage
  • Former removal of gingival graft in the palate
  • Smokers
  • Pregnancy and breastfeeding mothers
  • Use of anticonvulsants and immunosuppressors

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPhotobiomodulation

Irradiation with red laser on palate wound each 48h for 4 sessions.

OTHERProtection with surgical dressing

Protection of the palatal wound with surgical dressing for 7 days


Locations(1)

Bauru School of Dentistry

Bauru, São Paulo, Brazil

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06073678


Related Trials